Screener
Tarsus Pharmaceuticals, Inc. TARS Market capitalization
Market capitalization at other companies
Other financials
Where this comes from
Computed from the period-end share price: $2.71B.
The source filing: Tarsus Pharmaceuticals, Inc.’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 7:25 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001819790-26-000064
FAQ
- What is Tarsus Pharmaceuticals, Inc.'s market capitalization?
- Tarsus Pharmaceuticals, Inc. (TARS) reported market capitalization of $2.71B in Q2 2026.
- How has Tarsus Pharmaceuticals, Inc.'s market capitalization changed year-over-year?
- Tarsus Pharmaceuticals, Inc.'s market capitalization increased by 55.7% year-over-year, from $1.74B to $2.71B.
- What is the long-term trend for Tarsus Pharmaceuticals, Inc.'s market capitalization?
- Over 5 years (2020 to 2025), Tarsus Pharmaceuticals, Inc.'s market capitalization has grown at a 32.8% compound annual growth rate (CAGR), from $840.49M to $3.48B.
- What does market capitalization mean?
- The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.
Ask your AI about Tarsus Pharmaceuticals, Inc.'s market capitalization.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude